Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs directed at growing the horizons of cytokine-based immunotherapy, especially for cancers where remedy alternatives remain limited. Use the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Examine Our Pipeline We https://financefeeds.com/21x-taps-philip-filhol-for-business-development-ahead-of-exchange-launch/